Ramipril treatment in a patient with glycogen storage disease I non-A

Journal of Inherited Metabolic Disease

Volumn 25, Issue 6, 2002, Pages 515-516

  Gianni M L ^a   Bonvissuto, M ^a   Gallieni, M ^b   Testolin, C ^a   Racchi, E ^a   Riva, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE 6 PHOSPHATASE; PROTEIN; RAMIPRIL;

ADULT; ARTICLE; CASE REPORT; DIET THERAPY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ECHOGRAPHY; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; KIDNEY DISEASE; LIVER BIOPSY; MALE; PATIENT CARE; PROTEIN URINE LEVEL; PROTEINURIA; RENOVASCULAR HYPERTENSION; URINARY EXCRETION;

EID: 0036822215     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021263504104     Document Type: Article

References (3)

1. Baker L, Kern EFO, Olshan J, Goldfarb S, Dahlem ST (1988) Pilot study of captopril in patients with renal disease associated with glycogen storage disease type I (GSDI). Pediatr Res 23: 388A.
2. Ozen H, Ciliv G, Kocak N, Saltic IN, Yuce A, Gurakan F (2000) Short term effect of captopril on microalbuminuria in children with glycogen storage disease type Ia. J Inherit Metab Dis 23: 459-463.
3. Pela I, Donati M A, Zammarchi F (2001) Effect of ramipril in a patient with glycogen storage disease type I and nephrotic-range proteinuria. J Inherit Metab Dis 24: 681-682.